BindingDB logo
myBDB logout

12 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
28002667 51 Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe.EBI GlaxoSmithKline
27682507 167 Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300.EBI Genentech
27120693 2 An Advanced Tool To Interrogate BRD9.EBI Moffitt Cancer Center
26914985 124 Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor.EBI Boehringer Ingelheim RCV GmbH& Co KG
27190605 77 Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637).EBI Constellation Pharmaceuticals
26982797 20 The"Gatekeeper" Residue Influences the Mode of Binding of Acetyl Indoles to Bromodomains.EBI University of Z£rich
26572217 60 Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors.EBI Genentech
25799074 65 Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.EBI GlaxoSmithKline
25856009 33 Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.EBI GlaxoSmithKline R&D
26230603 176 Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors.EBI GlaxoSmithKline
25249180 146 The discovery of I-BET726 (GSK1324726A), a potent tetrahydroquinoline ApoA1 up-regulator and selective BET bromodomain inhibitor.EBI GlaxoSmithKline R&D
28949521 88 Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor.EBI AbbVie Inc.